March 14, 2023
In this interview, we speak with Mark Andrews, Investment Director, Life Sciences, Funds at British Patient Capital, the largest domestic …
March 1, 2023
Recently, David Dowling, a senior lawyer at Ropes & Gray, has outlined his predictions for M&A in the European biotech …
Jan. 17, 2023
Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …
Dec. 28, 2022
The aging research industry has exploded in recent years. Once a fringe area of science, aging research has now gained …
Dec. 22, 2022
The medical device industry is driven by constant innovation, and the annual Medica conference offers the chance to discover the …
Dec. 7, 2022
Tackling production inefficiencies, faulty products, and costly machine maintenance are just a few of the many issues that are hardly …
Nov. 6, 2022
While the pharmaceutical world is investigating biologics or mRNA-based therapies, Yochi Slonim, Israeli technology and biotech entrepreneur and public speaker …
Oct. 14, 2022
In contrast to molecular mechanics, which describes molecules as essentially “balls and sticks” kind of objects, taking into account only …
Aug. 17, 2022
Vaxess is a venture capital and Gates Foundation-backed company that is developing vaccine patches. Their mission is to significantly increase …
Aug. 15, 2022
Luciano Santollani is currently working towards his PhD at MIT developing novel cancer therapeutics, and is also working as a …
June 8, 2022
Acesis Biomed, a biotechnology company based in the US and the UK, is developing an innovative solution for the treatment …
May 3, 2022
The digitalization of clinical trials and the adoption of artificial intelligence (AI) has been a hot topic for a number …
